Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000187524 | SCV000241118 | uncertain significance | not provided | 2016-09-09 | criteria provided, single submitter | clinical testing | The c.549-3 T>G variant in the GABRG2 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. Several in-silico splice prediction models predict that c.549-3 T>G damages the natural acceptor site of intron 4 and leads to abnormal gene splicing. However, in the absence of RNA/functional studies, the actual effect of this sequence change in this individual is unknown. The c.549-3 T>G variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). We interpret c.549-3 T>G as a variant of uncertain significance. |
Ce |
RCV000187524 | SCV000493387 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | GABRG2: BP4 |
Labcorp Genetics |
RCV001234167 | SCV001406798 | uncertain significance | Epilepsy, childhood absence 2; Febrile seizures, familial, 8 | 2023-07-23 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. ClinVar contains an entry for this variant (Variation ID: 205543). This variant has been observed in individual(s) with Rolandic epilepsy (PMID: 25726841, 29358611). This variant is present in population databases (rs750459631, gnomAD 0.009%). This sequence change falls in intron 4 of the GABRG2 gene. It does not directly change the encoded amino acid sequence of the GABRG2 protein. It affects a nucleotide within the consensus splice site. |
Bioinformatics Core, |
RCV000655993 | SCV000588269 | pathogenic | Childhood epilepsy with centrotemporal spikes | 2017-01-01 | no assertion criteria provided | case-control | CAADphred>15 |